Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Supernus Pharmaceuticals Inc., 3 years.
Supernus Pharmaceuticals Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 24, 2026 | Supernus Pharmaceuticals Inc. | Grant or award | +4,475 | — | — |
| Nov 21, 2025 | Supernus Pharmaceuticals Inc. | Option exercise | +15,000 | $12.98 | $194,700 |
| Oct 9, 2025 | Supernus Pharmaceuticals Inc. | Open-market sale | −23,800 | $50.73 | $1,207,374 |
| Oct 9, 2025 | Supernus Pharmaceuticals Inc. | Open-market sale | −1,200 | $51.55 | $61,860 |
| Aug 27, 2025 | Supernus Pharmaceuticals Inc. | Open-market sale | −3,588 | $45.01 | $161,496 |
| Aug 25, 2025 | Supernus Pharmaceuticals Inc. | Open-market sale | −1,000 | $45.00 | $45,000 |
| Aug 22, 2025 | Supernus Pharmaceuticals Inc. | Open-market sale | −1,412 | $45.00 | $63,540 |
| Feb 22, 2025 | Supernus Pharmaceuticals Inc. | Grant or award | +5,369 | — | — |
| Nov 11, 2024 | Supernus Pharmaceuticals Inc. | Option exercise | +20,000 | $9.13 | $182,600 |
| Nov 11, 2024 | Supernus Pharmaceuticals Inc. | Open-market sale | −10,700 | $36.24 | $387,768 |
| Feb 23, 2024 | Supernus Pharmaceuticals Inc. | Grant or award | +3,886 | — | — |
| Nov 16, 2023 | Supernus Pharmaceuticals Inc. | Option exercise | +7,457 | $9.24 | $68,903 |
| Nov 16, 2023 | Supernus Pharmaceuticals Inc. | Open-market sale | −2,500 | $28.01 | $70,025 |
| Feb 22, 2023 | Supernus Pharmaceuticals Inc. | Grant or award | +3,882 | — | — |
| Apr 17, 2018 | Supernus Pharmaceuticals Inc. | Gift | −2,203 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.